The German firm, BioNTech, has signed deals with Rwanda and Senegal to build Africa’s first vaccine manufacturing facility based on mRNA technology. BioNTech, which with Pfizer created one of the world’s most widely used Covid-19 vaccines, says the plant will have an initial capacity to produce 50 million doses annually. …
Read More »